Efficacy of infliximab in refractory Behçet’s disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients

References

• PerkinsESFolkJUveitis in London and IowaOphthalmologica198418936406472804
   PubMed Web of Science ®Google Scholar
• HenderlyDEGenstlerAJSmithRERaoNAChanging patterns of uveitisAm J Ophthalmol19871031311363812615
   PubMed Web of Science ®Google Scholar
• WeinerABenEzraDClinical patterns and associated conditions in chronic uveitisAm J Ophthalmol19911121511581867298
   PubMed Web of Science ®Google Scholar
• RodriguezACalongeMPedroza-SeresMReferral patterns of uveitis in a tertiary eye care centerArch Ophthalmol19961145935998619771
   PubMed Web of Science ®Google Scholar
• JabsDANussenblattRBRosenbaumJTStandardization of Uveitis Nomenclature (SUN) Working GroupStandardization of uveitis nomenclature for reporting clinical data. Results of the first international workshopAm J Ophthalmol200514050951616196117
   PubMed Web of Science ®Google Scholar
• RathinamSRNamperumalsamyPGlobal variation and pattern changes in epidemiology of uveitisIndian J Ophthalmol200755317318317456933
   PubMedGoogle Scholar
• KaçmazROKempenJHNewcombCOcular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuityAm J Ophthalmol200814682883618708181
   PubMed Web of Science ®Google Scholar
• KumpLIMoellerKLReedGFKurupSKNussenblattRBLevy-ClarkeGABehçet’s disease: comparing 3 decades of treatment response at the National Eye InstituteCan J Ophthalmol20084346847218711463
   PubMed Web of Science ®Google Scholar
• Tugal-TutkunIOnalSAltan-YayciogluRHuseyin AltunbasHUrganciogluMUveitis in Behçet disease: an analysis of 880 patientsAm J Ophthalmol200413837338015364218
   PubMed Web of Science ®Google Scholar
• PatoEMuñoz-FernándezSFranciscoFAbadMAMaeseJOrtizASystematic review on the effectiveness of immunosuppressants and biological therapies in the treatment of autoimmune posterior uveitisSemin Arthritis Rheum20114031432320656330
   PubMed Web of Science ®Google Scholar
• IlhanFDemirTTürkçüođluPTurgutBDemirNGödekmerdanATh1 polarization of the immune response in uveitis in Behçet’s diseaseCan J Ophthalmol20084310510818204495
   PubMed Web of Science ®Google Scholar
• AhadMAMissottenTAbdallahALympanyPALightmanSPolymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitisMol Vis20071338839617417600
   PubMed Web of Science ®Google Scholar
• OkadaAASakaiJUsuiMIntraocular cytokine quantification of experimental autoimmune uveoretinitis in ratsOcul Immunol Inflamm199861111209689641
   PubMed Web of Science ®Google Scholar
• CalderVLShaerBMuhayaMIncreased CD4+ expression and decreased IL-10 in the anterior chamber in idiopathic uveitisInvest Ophthalmol Vis Sci1999402019202410440256
   PubMed Web of Science ®Google Scholar
• RobertsonMLiversidgeJForresterJVNeutralizing tumor necrosis factor-alpha activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitisInvest Ophthalmol Vis Sci2003443034304112824249
   PubMed Web of Science ®Google Scholar
• GreinerKMurphyCCWillermainFAnti-TNFalpha therapy modulates the phenotype of peripheral blood CD4+ T cells in patients with posterior segment intraocular inflammationInvest Ophthalmol Vis Sci20044517017614691170
   PubMed Web of Science ®Google Scholar
• Santos LacombaMMarcos MartinCGallardo GaleraJMAqueous humor and serum tumor necrosis factor-alpha in clinical uveitisOphthalmic Res20013325125511586057
   PubMed Web of Science ®Google Scholar
• LarsonTNussenblattRBSenHNEmerging drugs for uveitisExpert Opin Emerg Drugs20111630932221210752
   PubMed Web of Science ®Google Scholar
• NiccoliLNanniniCBenucciMLong-term efficacy of infliximab in refractory posterior uveitis of Behçet’s disease: a 24-month follow-up studyRheumatology (Oxford)20074671161116417478466
   PubMed Web of Science ®Google Scholar
• JabsDARosenbaumJTFosterCSGuidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panelAm J Ophthalmol200013049251311024423
   PubMed Web of Science ®Google Scholar
• International Study Group for Behçet’s diseaseCriteria for diagnosis of Behçet’s diseaseLancet1990335107810801970380
   PubMed Web of Science ®Google Scholar
• Tugal-TutkunIBehçet’s uveitisMiddle East Afr J Ophthalmol20091621922420404988
   PubMedGoogle Scholar
• GoossensPHVerburgRJBreedveldFCRemission of Behçet’s syndrome with tumour necrosis factor alpha blocking therapyAnn Rheum Dis20016063711350856
   PubMed Web of Science ®Google Scholar
• Muñoz-FernándezSHidalgoVFernández-MelónJSchlinckerAMartín-MolaEEffect of infliximab on threatening panuveitis in Behçet’s diseaseLancet20013581644
   PubMed Web of Science ®Google Scholar
• TrioloGVadalàMAccardo-PalumboAAnti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet’s diseaseAnn Rheum Dis20026156056112006336
   PubMed Web of Science ®Google Scholar
• MorrisDSGavinMPSturrockRDThe effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet’s diseaseAdv Exp Med Biol200352855755912918763
   PubMed Web of Science ®Google Scholar
• GiansantiFBarberaMLVirgiliGPieriBEmmiLMenchiniUInfliximab for the treatment of posterior uveitis with retinal neovascularization in Behçet diseaseEur J Ophthalmol20041444544815506610
   PubMed Web of Science ®Google Scholar
• TakamotoMKaburakiTNumagaJFujinoYKawashimaHLong-term infliximab treatment for Behçet’s diseaseJpn J Ophthalmol20075123924017554493
   PubMed Web of Science ®Google Scholar
• OlivieriILatanzaLSiringoSPeruzGDi IorioVSuccessful treatment of severe Behçet’s disease with infliximab in an Italian Olympic athleteJ Rheumatol20083593093218464316
   PubMed Web of Science ®Google Scholar
• OlivieriIPadulaALeccesePD’AngeloSGiasiVLong-lasting remission of severe Behçet’s disease after the end of infliximab therapyJ Rheumatol20093685519342728
   PubMed Web of Science ®Google Scholar
• AlokailyFAlsalehSAl-BalawiMAl-RashidiSEfficacy of infliximab on the acute attack of uveitisSaudi Med J201031828520062906
   PubMed Web of Science ®Google Scholar
• DonghiDMainettiCInfliximab for the treatment of refractory Adamantiades-Behçet disease with articular, intestinal, cerebral and ocular involvementDermatology201022028228620110641
   PubMed Web of Science ®Google Scholar
• KawaguchiTSugitaSYamadaYMiyanagaMMochizukiMRegression of optic disc neovascularization in patients with Behçet’s uveoretinitis after infliximab therapyJ Ocul Pharmacol Ther20102662763021043804
   PubMed Web of Science ®Google Scholar
• Sf ikakisPPTheodossiadisPGKatsiariCGKaklamanisPMarkomichelakisNNEffect of infliximab on sight-threatening panuveitis in Behçet’s diseaseLancet200135829529611498218
   PubMed Web of Science ®Google Scholar
• JosephARajDDuaHSPowellPTLanyonPCPowellRJInfliximab in the treatment of refractory posterior uveitisOphthalmology20031101449145312867408
   PubMed Web of Science ®Google Scholar
• SfikakisPPKaklamanisPHElezoglouAInfliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet diseaseAnn Intern Med200414040440614996689
   PubMed Web of Science ®Google Scholar
• OhnoSNakamuraSHoriSEfficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet’s disease with refractory uveoretinitisJ Rheumatol2004311362136815229958
   PubMed Web of Science ®Google Scholar
• WechslerBSablé-FourtassouRBodaghiBInfliximab in refractory uveitis due to Behçet’s diseaseClin Exp Rheumatol2004224 Suppl 34S14S1615515776
   PubMed Web of Science ®Google Scholar
• Benitez-del-CastilloJMMartinez-de-la-CasaJMPato-CourELong-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab)Eye (Lond)20051984184515389273
   PubMed Web of Science ®Google Scholar
• Tugal-TutkunIMudunAUrganciogluMEfficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet’s disease: an open-label trialArthritis Rheum2005522478248416052571
   PubMed Web of Science ®Google Scholar
• LindstedtEWBaarsmaGSKuijpersRWvan HagenPMAnti- TNF-alpha therapy for sight threatening uveitisBr J Ophthalmol20058953353615834077
   PubMed Web of Science ®Google Scholar
• LanthierNParcCScavennecRDhôteRBrézinAPGuilleviLInfliximab in the treatment of posterior uveitis in Behçet’s disease. Long term follow up in four patientsPresse Med20053491691816142147
   PubMed Web of Science ®Google Scholar
• SuhlerEBSmithJRWertheimMSA prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomesArch Ophthalmol200512390391216009830
   PubMed Web of Science ®Google Scholar
• MushtaqBSaeedTSitunayakeRDMurrayPIAdalimumab for sight-threatening uveitis in Behçet’s diseaseEye (Lond)20072182482516601736
   PubMed Web of Science ®Google Scholar
• Abu El-AsrarAMAbboudEBAldibhiHAl-ArfajALong-term safety and efficacy of infliximab therapy in refractory uveitis due to Behçet’s diseaseInt Ophthalmol200526839217031510
   PubMedGoogle Scholar
• AccorintiMPirragliaMPParoliMPPrioriRContiFPivetti-PezziPInfliximab treatment for ocular and extraocular manifestations of Behçet’s diseaseJpn J Ophthalmol20075119119617554481
   PubMed Web of Science ®Google Scholar
• TognonSGrazianiGMarcolongoRAnti-TNF-alpha therapy in seven patients with Behçet’s uveitis: advantages and controversial aspectsAnn N Y Acad Sci2007111047448417911463
   PubMed Web of Science ®Google Scholar
• Al-RayesHAl-SwailemRAl-BalawiMAl-DohayanNAl-ZaidiSTariqMSafety and efficacy of infliximab therapy in active Behçet’s uveitis: an open-label trialRheumatol Int200829535718496694
   PubMed Web of Science ®Google Scholar
• TabbaraKFAl-HemidanAIInfliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet diseaseAm J Ophthalmol200814684585018929351
   PubMed Web of Science ®Google Scholar
• YamadaYSugitaSTanakaHKamoiKKawaguchiTMochizukiMComparison of infliximab versus cyclosporin during the initial 6-month treatment period in Behçet diseaseBr J Ophthalmol20109428428819692382
   PubMed Web of Science ®Google Scholar
• GiardinaAFerranteACicciaFVadalàMGiardinaETrioloGOne year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet’s disease refractory to standard immunosuppressive drugsRheumatol Int201131333719859715
   PubMed Web of Science ®Google Scholar
• AdánAHernandezVOrtizSEffects of infliximab in the treatment of refractory posterior uveitis of Behçet’s disease after withdrawal of infusionsInt Ophthalmol201030557758120490893
   PubMed Web of Science ®Google Scholar
• YamadaYSugitaSTanakaHKamoiKTakaseHMochizukiMTiming of recurrent uveitis in patients with Behcet’s disease receiving infliximab treatmentBr J Ophthalmol20119520520820542984
   PubMed Web of Science ®Google Scholar
• SugitaSYamadaYMochizukiMRelationship between serum infliximab levels and acute uveitis attacks in patients with Behçet diseaseBr J Ophthalmol20119554955220584716
   PubMed Web of Science ®Google Scholar
• RothovaASuttorp-van SchultenMSFrits TreffersWKijlstraACauses and frequency of blindness in patients with intraocular inflammatory diseaseBr J Ophthalmol1996803323368703885
   PubMed Web of Science ®Google Scholar
• DurraniOMTehraniNNMarrJEMoradiPStavrouPMurrayPIDegree, duration, and causes of visual loss in uveitisBr J Ophthalmol2004881159116215317708
   PubMed Web of Science ®Google Scholar
• The Multicenter Uveitis Steroid Treatment Trial Research GroupKempenJHAltaweelMMHolbrookJTJabsDASugarEAThe multicenter uveitis steroid treatment trial: rationale, design and baseline characteristicsAm J Ophthalmol201014955056120097325
   PubMed Web of Science ®Google Scholar
• KempenJHGaneshSKSangwanVSRathinamSRInterobserver agreement in grading activity and site of inflammation in eyes of patients with uveitisAm J Ophthalmol200814681381818687418
   PubMed Web of Science ®Google Scholar
• Tugal-TutkunICinguKKirNYeniadBUrganciogluMGulAUse of laser flare-cell photometry to quantify intraocular inflammation in patients with Behçet’s uveitisGraefes Arch Clin Exp Ophthalmol20082461169117718504599
   PubMed Web of Science ®Google Scholar
• SfikakisPPThe first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directionsCurr Dir Autoimmun20101118021020173395
   PubMedGoogle Scholar
• MarkomichelakisNNTheodossiadisPGPanteliaEPapaefthimiouSTheodossiadisGPSfikakisPPInfliximab for chronic cystoid macular edema associated with uveitisAm J Ophthalmol200413864865015488796
   PubMed Web of Science ®Google Scholar
• de VriesJBaarsmaGSZaalMJWCyclosporin in the treatment of severe chronic idiopathic uveitisBr J Ophthalmol1990743443492198928
   PubMed Web of Science ®Google Scholar